Acadia Healthcare (ACHC) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Acadia Healthcare · Health Care · ref. ETF XLV · 56 calls · price $30.23
What the company does: Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico.
📈 Acadia Healthcare (ACHC) stock price
$30.23+21.3% over range
Oct 14, 25low $11.68 · high $35.61Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
67% recommend buying · 9 analysts
📊 JPI status :
Acadia Healthcare is part of our 2026 selection (JPI Fair), bought at the start of the year and tracked live. It no longer shows in today's ranking: its target has been reached, there is no gap left. See the 2026 selection and its performance →
🎯 ACHC price target & analyst consensus — price $30.23
The price target · all analysts combined (9 targets)
Highest target · 1 firm of 9$40+32.3%
Median target · of 9 targets$33+9.2%
Lowest target · 2 firms of 9$30-0.8%
Current price$30.23
Where these 9 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
778%
$31 ↔ $40
Below
222%
$30
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Guggenheim — 69% of its targets hit on this sector (51 calls tested). It aims for $39 (+29 %), call made on July 31, 2026, maturing on July 31, 2027 (75 d ago).
The 2 reliable analysts
$36+19 %
The 7 other firms
$32+5.9 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $36 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 9 ratings (last 6 months)
Strong Buy00%
Buy667%
Hold333%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ACHC price target all
All 56 calls, one by one, with our verdict on each firm.
→ See all 56 targets, analyst by analyst💡 The best analysts on ACHC most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ACHC? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Acadia Healthcare? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on ACHC
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Jefferies ↗ | 75% | +42.2% | 4 |
| B of A Securities ↗ | 71% | +5.7% | 7 |
| Raymond James ↗ | 70% | +39.8% | 10 |
| BMO Capital ↗ | 67% | +36.6% | 6 |
| Credit Suisse | 67% | +10.4% | 6 |
| Guggenheim ↗ | 50% | +30.5% | 2 |
| UBS ↗ | 43% | -0.3% | 7 |
| Citigroup ↗ | 40% | +16.0% | 5 |
| SVB Leerink | 40% | +4.9% | 5 |
| Keybanc ↗ | 40% | -22.7% | 5 |
See the other 4 firms
| RBC Capital ↗ | 9% | -34.3% | 11 |
| Barclays ↗ | 12% | -51.2% | 8 |
| TD Cowen ↗ | 25% | -33.2% | 4 |
| Deutsche Bank ↗ | 33% | -16.2% | 6 |
📊 What $1,000 invested in Acadia Healthcare would be worth › open the full page
In short — $1,000 invested in Acadia Healthcare 10 years ago would be worth $506 today, i.e. -7%/yr on average. Best year: 2020 (+51%), worst: 2025 (-64%). Price performance, excluding dividends.
If I'd invested $1,000 in Acadia Healthcare
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $797 | -20% |
| 3 years ago | $384 | -62% |
| 5 years ago | $629 | -37% |
Return by year (Acadia Healthcare)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +123% | $2,227 (+123%) |
| 2025 | -64% | $797 (-20%) |
| 2024 | -49% | $406 (-59%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Acadia Healthcare
Loading news…
📋 All analyst calls on ACHC
Filtered on — · ✕ show all
Leerink Partners ↗
Sep 23, 26
■ Market Perform neutral · not a buy · 🎯$33
Price at call : $28.51 — gap to target +16%
Today : $30.23 — gap to target +9%
🎯 on ACHC : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Sep 23, 27
matures : Sep 23, 27
Guggenheim ↗
Jul 30, 26
▲ Buy · 🎯$39
Price at call : $29.62 — upside +32%
Today : $30.23 — upside +29%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
■ Equal-Weight neutral · not a buy · 🎯$32
Price at call : $28.14 — gap to target +14%
Today : $30.23 — gap to target +6%
🎯 on ACHC : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Guggenheim ↗
Jul 20, 26
▲ Buy · 🎯$38
Price at call : $34.43 — upside +10%
Today : $30.23 — upside +26%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : Jul 20, 27
matures : Jul 20, 27
Guggenheim ↗
Jul 20, 26
▲ Buy · 🎯$150
Price at call : $34.43 — upside +336%
Today : $30.23 — upside +396%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : Jul 20, 27
matures : Jul 20, 27
▲ Buy · 🎯$36
Price at call : $32.27 — upside +12%
Today : $30.23 — upside +19%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
▲ Overweight · 🎯$40
Price at call : $31.6 — upside +27%
Today : $30.23 — upside +32%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 23.6% · -18.3% (110 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
▲ Buy · 🎯$39
Price at call : $31.28 — upside +25%
Today : $30.23 — upside +29%
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
See the other 48 calls, newest to oldest
▲ Buy · 🎯$30
Price at call : $25.21 — upside +19%
Today : $30.23 — upside -1%
🎯 on ACHC : no call matured yet · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
RBC Capital ↗
May 4, 26
▲ Outperform · 🎯$31
Price at call : $25.27 — upside +23%
Today : $30.23 — upside +3%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Guggenheim ↗
May 4, 26
▲ Buy · 🎯$31
Price at call : $27.69 — upside +12%
Today : $30.23 — upside +3%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Cantor Fitzgerald ↗
May 1, 26
■ Neutral neutral · not a buy · 🎯$30
Price at call : $27.69 — gap to target +8%
Today : $30.23 — gap to target -1%
🎯 on ACHC : no call matured yet · 📊 on Health : 50% · +13.4% (168 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
■ Equal-Weight neutral · not a buy · 🎯$25
Price at call : $27.69 — gap to target -10%
Today : $30.23 — gap to target -17%
🎯 on ACHC : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
▲ Buy · 🎯$30
Price at call : $28.26 — upside +6%
Today : $30.23 — upside -1%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Apr 28, 27
matures : Apr 28, 27
▲ Buy · 🎯$31
Price at call : $27.84 — upside +11%
Today : $30.23 — upside +3%
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $24.07 — gap to target -17%
Today : $30.23 — gap to target -34%
🎯 on ACHC : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Mar 3, 27
matures : Mar 3, 27
Leerink Partners ↗
Feb 26, 26
■ Market Perform neutral · not a buy · 🎯$22
Price at call : $23.44 — gap to target -6%
Today : $30.23 — gap to target -27%
🎯 on ACHC : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$27
Price at call : $23.44 — upside +15%
Today : $30.23 — upside -11%
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$24
Price at call : $23.44 — upside +2%
Today : $30.23 — upside -21%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
RBC Capital ↗
Feb 26, 26
▲ Outperform · 🎯$28
Price at call : $23.44 — upside +19%
Today : $30.23 — upside -7%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Guggenheim ↗
Feb 23, 26
▲ Buy · 🎯$22
Price at call : $17.17 — upside +28%
Today : $30.23 — upside -27%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : Feb 23, 27
matures : Feb 23, 27
■ Hold neutral · not a buy · 🎯$15
Price at call : $15.15 — gap to target -1%
Today : $30.23 — gap to target -50%
🎯 on ACHC : no call matured yet · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
▲ Buy · 🎯$22
Price at call : $14.24 — upside +54%
Today : $30.23 — upside -27%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
RBC Capital ↗
Jan 14, 26
▲ Outperform · 🎯$17
Price at call : $11.91 — upside +43%
Today : $30.23 — upside -44%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Jan 14, 27
matures : Jan 14, 27
■ Neutral neutral · not a buy · 🎯$17
Price at call : $14.43 — gap to target +18%
Today : $30.23 — gap to target -44%
🎯 on ACHC : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
■ Equal-Weight neutral · not a buy · 🎯$14
Price at call : $15.47 — gap to target -10%
Today : $30.23 — gap to target -54%
🎯 on ACHC : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Dec 4, 26
matures : Dec 4, 26
RBC Capital ↗
Dec 3, 25
▲ Outperform · 🎯$19
Price at call : $14.64 — upside +30%
Today : $30.23 — upside -37%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
Cantor Fitzgerald ↗
Dec 3, 25
■ Neutral neutral · not a buy · 🎯$17
Price at call : $14.64 — gap to target +16%
Today : $30.23 — gap to target -44%
🎯 on ACHC : no call matured yet · 📊 on Health : 50% · +13.4% (168 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
▲ Overweight · 🎯$25
Price at call : $14.64 — upside +71%
Today : $30.23 — upside -17%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 23.6% · -18.3% (110 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
▲ Buy · 🎯$24
Price at call : $14.64 — upside +64%
Today : $30.23 — upside -21%
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
Deutsche Bank ↗
Dec 3, 25
▲ Buy · 🎯$20
Price at call : $14.64 — upside +37%
Today : $30.23 — upside -34%
🎯 on ACHC : no call matured yet · 📊 on Health : 33.9% · -7.0% (56 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
B of A Securities ↗
Dec 3, 25
▼ Underperform · 🎯$13
Price at call : $14.69 — upside -12%
Today : $30.23 — upside -57%
🎯 on ACHC : no call matured yet · 📊 on Health : 51.9% · +3.9% (156 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
Leerink Partners ↗
Dec 3, 25
■ Market Perform neutral · not a buy · 🎯$14
Price at call : $14.69 — gap to target -5%
Today : $30.23 — gap to target -54%
🎯 on ACHC : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
▲ Overweight · 🎯$30
Price at call : $14.34 — upside +109%
Today : $30.23 — upside -1%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 23.6% · -18.3% (110 calls)
in progress (365j)
matures : Nov 18, 26
matures : Nov 18, 26
RBC Capital ↗
Nov 12, 25
▲ Outperform · 🎯$22
Price at call : $17.41 — upside +26%
Today : $30.23 — upside -27%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Nov 12, 26
matures : Nov 12, 26
Guggenheim ↗
Nov 10, 25
▲ Buy · 🎯$27
Price at call : $18.24 — upside +48%
Today : $30.23 — upside -11%
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
▲ Buy · 🎯$28
Price at call : $18.17 — upside +54%
Today : $30.23 — upside -7%
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Cantor Fitzgerald ↗
Nov 7, 25
■ Neutral neutral · not a buy · 🎯$22
Price at call : $18.17 — gap to target +21%
Today : $30.23 — gap to target -27%
🎯 on ACHC : no call matured yet · 📊 on Health : 50% · +13.4% (168 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
■ Equal-Weight neutral · not a buy · 🎯$17
Price at call : $20.26 — gap to target -16%
Today : $30.23 — gap to target -44%
🎯 on ACHC : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Overweight · 🎯$35
Price at call : $25.6 — upside +37%
Today : $30.23 — upside +16%
Expected +37% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 23.6% · -18.3% (110 calls)
+11.3%
stock +11% · XLV +16%
matured Oct 8, 26
Cantor Fitzgerald ↗
Oct 7, 25
■ Neutral neutral · not a buy · 🎯$25
Price at call : $27.23 — gap to target -8%
Today : $30.23 — gap to target -17%
🎯 on ACHC : no call matured yet · 📊 on Health : 50% · +13.4% (168 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
Raymond James ↗
Oct 3, 25
▲ Outperform · 🎯$30
Price at call : $26.46 — upside +13%
Today : $30.23 — upside -1%
Expected +13% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on ACHC : 100% (2 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
+9.1%
stock +9% · XLV +16%
matured Oct 3, 26
B of A Securities ↗
Sep 10, 25
■ Neutral neutral · not a buy · 🎯$25
Price at call : $22.31 — gap to target +12%
Today : $30.23 — gap to target -17%
🎯 on ACHC : no call matured yet · 📊 on Health : 51.9% · +3.9% (156 calls)
in progress (365j)
matures : Sep 10, 26
matures : Sep 10, 26
Raymond James ↗
Aug 14, 25
▲ Outperform · 🎯$26
Price at call : $20.66 — upside +26%
Today : $30.23 — upside -14%
Expected +26% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on ACHC : 100% (2 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
+49.2%
stock +49% · XLV +25%
matured Aug 14, 26
■ Neutral neutral · not a buy · 🎯$22
Price at call : $20.66 — gap to target +6%
Today : $30.23 — gap to target -27%
🎯 on ACHC : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Aug 14, 26
matures : Aug 14, 26
RBC Capital ↗
Aug 13, 25
▲ Outperform · 🎯$28
Price at call : $20.66 — upside +36%
Today : $30.23 — upside -7%
Expected +36% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 31.1% · -10.5% (167 calls)
+49.2%
stock +49% · XLV +25%
matured Aug 13, 26
▲ Buy · 🎯$25
Price at call : $19.24 — upside +30%
Today : $30.23 — upside -17%
Expected +30% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 50% · -1.0% (40 calls)
+65.2%
stock +65% · XLV +29%
matured Aug 7, 26
▲ Buy · 🎯$31
Price at call : $19.24 — upside +61%
Today : $30.23 — upside +3%
Expected +61% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
+65.2%
stock +65% · XLV +29%
matured Aug 7, 26
Guggenheim ↗
Aug 7, 25
▲ Buy · 🎯$29
Price at call : $19.24 — upside +51%
Today : $30.23 — upside -4%
Expected +51% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on ACHC : 100% (1 call matured) · 📊 on Health : 64.7% · +17.5% (51 calls)
+65.2%
stock +65% · XLV +29%
matured Aug 7, 26
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $18.2 — gap to target +10%
Today : $30.23 — gap to target -34%
🎯 on ACHC : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Aug 7, 26
matures : Aug 7, 26
▲ Buy · 🎯$102
Price at call : $83.45 — upside +22%
Today : $30.23 — upside +237%
Expected +22% · Actual -64% · Reason (≥ +15%) : ✗ No
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
-64.1%
stock -64% · XLV +3%
matured Feb 27, 25
▲ Buy · 🎯$92
Price at call : $73.87 — upside +25%
Today : $30.23 — upside +204%
Expected +25% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
-4.2%
stock -4% · XLV +5%
matured Apr 23, 24
▲ Buy · 🎯$90
Price at call : $81.68 — upside +10%
Today : $30.23 — upside +198%
Expected +10% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
-2.8%
stock -3% · XLV +2%
matured Jul 28, 23
▲ Buy · 🎯$81
Price at call : $65.15 — upside +24%
Today : $30.23 — upside +168%
Expected +24% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
+18.3%
stock +18% · XLV -8%
matured Sep 24, 22
▲ Buy · 🎯$60
Price at call : $52.09 — upside +15%
Today : $30.23 — upside +98%
Expected +15% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on ACHC : 43% (7 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
-22.5%
stock -22% · XLV +12%
matured Jul 31, 18
Frequently asked questions
Should I buy Acadia Healthcare stock?
This isn't buy advice. For Acadia Healthcare, the analyst consensus is "Buy", with an average price target of $33.00 (+9% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 75% of the time (4 calls tracked on Acadia Healthcare). We show the numbers — you decide.
Is it too late to buy Acadia Healthcare? How high can it go?
The most bullish analyst target on Acadia Healthcare is $40.00 (+32% above today's price); the average is $33.00. That's the upside they see. Check how reliable those analysts have actually been on Acadia Healthcare on our site before trusting it.
Is Acadia Healthcare still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 14 analysts have a real record on Acadia Healthcare, the best hitting 75% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Acadia Healthcare? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ACHC (and why hesitate).
What has Acadia Healthcare's past performance been?
Historical returns and a "how much if I had invested" calculator: ACHC performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX